ResearcherBiomedical Research Networking Center in Bioengineering, Biomaterials and NanomedicineActive in the last 2 years
Omar F. Luna
Matched on ORCID iD 0000-0002-1392-8006; OpenAlex author ID A5081794422. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2024: 1 paper · 2025: 1 paper
Papers 2
- Anti-Tumor Efficacy of a Mesothelin-Based Nanovaccine in a KPC Orthotopic Mouse Model of Pancreatic Cancer. Co-author DOI 10.3390/vaccines13030314↗
- Impact of N-Terminal PEGylation on Synthesis and Purification of Peptide-Based Cancer Epitopes for Pancreatic Ductal Adenocarcinoma (PDAC). Co-author DOI 10.1021/acsomega.4c02604↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Frauke Alves · 2 shared papers, 2024–2025 · strength 0.42
- Paper Anti-Tumor Efficacy of a Mesothelin-Based Nanovaccine in a KPC Orthotopic Mouse Model of Pancreatic Cancer. DOI 10.3390/vaccines13030314↗
- Paper Impact of N-Terminal PEGylation on Synthesis and Purification of Peptide-Based Cancer Epitopes for Pancreatic Ductal Ad… DOI 10.1021/acsomega.4c02604↗
- Daniele Pereira Ferrari · 2 shared papers, 2024–2025 · strength 0.42
- Paper Anti-Tumor Efficacy of a Mesothelin-Based Nanovaccine in a KPC Orthotopic Mouse Model of Pancreatic Cancer. DOI 10.3390/vaccines13030314↗
- Paper Impact of N-Terminal PEGylation on Synthesis and Purification of Peptide-Based Cancer Epitopes for Pancreatic Ductal Ad… DOI 10.1021/acsomega.4c02604↗
- Fernando Alberício · 2 shared papers, 2024–2025 · strength 0.42
- Paper Anti-Tumor Efficacy of a Mesothelin-Based Nanovaccine in a KPC Orthotopic Mouse Model of Pancreatic Cancer. DOI 10.3390/vaccines13030314↗
- Paper Impact of N-Terminal PEGylation on Synthesis and Purification of Peptide-Based Cancer Epitopes for Pancreatic Ductal Ad… DOI 10.1021/acsomega.4c02604↗
- Fernanda Ramos‐Gomes · 1 shared paper, 2025 · strength 0.22
- M. Andrea Markus · 1 shared paper, 2025 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.